맞춤형 가정 의약품 올바른 보관 가이드 생성

집

AI 프롬프트 목록

의료 건강

가정 상용의약품 보관 가이드 생성

${:__('collect %s',가정 상용의약품 보관 가이드 생성)}$

의료 건강

사용자의 가정 보관 환경과 상용 의약품 유형에 따라 안전 기준을 충족하는 가정 의약품 보관 가이드를 생성하고 부적절한 보관의 위험을 알립니다.

프롬프트 내용

복사

Based on the user's provided list of regular home medications and the available storage locations and environment at home, sort out suitable storage conditions for each drug, mark drugs that require light avoidance, refrigeration or sealed storage, explain the efficacy reduction and safety risks caused by improper storage, and give clear and easy-to-follow suggestions for arranging and organizing home medications.

복사

사용자가 제공한 가정 상용 의약품 목록과 가정 내 의약품 보관 가능 장소 환경을 바탕으로 각 의약품에 적합한 보관 조건을 정리하고, 차광, 냉장 또는 밀봉 보관이 필요한 의약품을 표시하며, 부적절한 보관으로 인한 효능 저하와 안전 위험을 설명하고, 이해하기 쉬운 가정 의약품 정리 배치 제안을 제공합니다.

복사

공유 링크를 복사하려면 클릭

의견 (0)

0/300

제출하다

추천

처방전 감사 어시스턴트

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all proposed drug names and dosages. Second, based on the latest clinical guidelines and package inserts, check for drug-drug interactions, contraindications, and dosage adjustments for special populations (e.g., hepatic or renal impairment). Finally, if any potential risks or inappropriate usage are identified, clearly specify the issues and provide evidence-based optimization suggestions or alternative regimens, ensuring the output is objective, professional, and compliant with medical safety standards.

처방전 심사 어시스턴트

Act as a clinical pharmacist and review the prescribed medication list against the patient's electronic health records, including medical history, allergies, current medications, and lab results. Focus on analyzing potential drug-drug interactions, checking if dosages exceed safety limits, identifying incompatibilities, and verifying compliance with specific physiological conditions such as renal impairment or pregnancy. Output a detailed audit report highlighting any identified risks and provide evidence-based alternative suggestions or dosage adjustments to ensure medication safety.

처방전 심사 보조자

Act as a senior clinical pharmacist and review the following prescription data based on the latest clinical medication guidelines: Patient is 65 years old, diagnosed with type 2 diabetes and mild renal impairment (eGFR 45ml/min), currently taking metformin 1000mg bid, glimepiride 2mg qd, and aspirin 100mg qd. Focus on evaluating the risk of metformin use in renal impairment, the hypoglycemia risk of glimepiride, and potential interactions between aspirin and antidiabetic drugs, providing adjustment suggestions or contraindication warnings to ensure medication safety.

처방전 심사 어시스턴트

Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Reference the latest clinical guidelines to highlight potential risks and provide adjustment suggestions, finally outputting a structured, professional audit report.

수술 후 재활 보조 도구

Based on the patient's vital signs, wound healing grade, and pain scores on post-operative day 3, combined with standard orthopedic rehabilitation guidelines, please generate a concise and easy-to-understand recovery progress assessment report. The report should include the current recovery stage judgment, potential risk warnings, and key home care suggestions for the next week. The language should be gentle and professional, avoiding complex medical jargon to ensure patient comprehension and compliance.

처방전 심사 어시스턴트

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all prescribed drug names and dosages. Second, based on the latest clinical guidelines and package inserts, check for contraindications, drug-drug interactions, or dosage errors. Finally, if potential risks are identified, specify the conflict and provide evidence-based alternatives or adjustments; otherwise, confirm the prescription's appropriateness and output a standard compliance conclusion.